or Try an Advanced Search...

    Technical Analysis for TBPH - Theravance Biopharma, Inc.

    Grade Last Price % Change Price Change
    C 9.68 -1.73% -0.17
    TBPH closed up 4.9 percent on Wednesday, May 15, 2024, on 69 percent of normal volume. The stock crossed above its 200 day moving average, improving its long-term outlook by crossing above that critical trendline.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Up Up
    Historical TBPH trend table...
    Date Alert Name Type % Chg
    Crossed Above 200 DMA Bullish -1.73%
    180 Bullish Setup Bullish Swing Setup -1.73%
    Inside Day Range Contraction -1.73%
    Gapped Up Strength -1.73%
    Upper Bollinger Band Touch Strength -1.73%
    200 DMA Resistance Bearish 3.09%
    Earnings Movers Other 3.09%
    Outside Day Range Expansion 3.09%
    Gapped Up Strength 3.09%
    Upper Bollinger Band Touch Strength 3.09%
    Older End-of-Day Signals for TBPH ...

       Recent Intraday Alerts

    Alert Time
    200 DMA Support about 3 hours ago
    10 DMA Support about 3 hours ago
    60 Minute Opening Range Breakdown about 4 hours ago
    Fell Below Previous Day's Low about 4 hours ago
    Down 1 ATR about 4 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    TBPH Chart by TradingView
    Basic chart:

    Profile

    Theravance Biopharma, Inc. operates as a biopharmaceutical company. It provides discovery, development, and commercialization of small molecule medicines primarily for therapeutic areas of respiratory diseases, bacterial infections, and central nervous system (CNS)/pain. The company is based in George Town, Cayman Islands. Theravance Biopharma, Inc. operates as a subsidiary of Theravance Inc.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biopharmaceutical Pain Medication Respiratory Diseases Bacterial Infections

    Is TBPH a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 2 bullish, 0 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 14 Theravance (TBPH) Q1 Earnings Top, Revenues Match Estimates
    May 13 Theravance Biopharma, Inc. (TBPH) Q1 2024 Earnings Call Transcript
    May 13 Theravance Biopharma (TBPH) Reports Q1 Loss, Misses Revenue Estimates
    May 13 Theravance Biopharma GAAP EPS of -$0.24 beats by $0.01, revenue of $14.51M beats by $0.56M
    May 13 Theravance Biopharma, Inc. Reports First Quarter 2024 Financial Results and Provides Business Update
    May 12 Theravance Biopharma Q1 2024 Earnings Preview
    May 9 Theravance Biopharma to Participate in an Upcoming Investor Conference
    Apr 29 Theravance Biopharma to Report First Quarter 2024 Financial Results on May 13, 2024
    Apr 15 BTIG Research Predicts Over 118% Rally for These 3 Stocks
    Apr 15 Strength Seen in Theravance Bio (TBPH): Can Its 7.6% Jump Turn into More Strength?
    See more TBPH news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 11.71
    52 Week Low 8.21
    Average Volume 413,523
    200-Day Moving Average 9.59
    50-Day Moving Average 9.14
    20-Day Moving Average 9.30
    10-Day Moving Average 9.51
    Average True Range 0.42
    RSI (14) 60.00
    ADX 21.09
    +DI 26.96
    -DI 14.45
    Chandelier Exit (Long, 3 ATRs) 9.12
    Chandelier Exit (Short, 3 ATRs) 9.65
    Upper Bollinger Bands 9.90
    Lower Bollinger Band 8.70
    Percent B (%b) 0.96
    BandWidth 12.91
    MACD Line 0.11
    MACD Signal Line 0.07
    MACD Histogram 0.0417
    Fundamentals Value
    Market Cap 490.51 Million
    Num Shares 49.8 Million
    EPS -1.03
    Price-to-Earnings (P/E) Ratio -9.56
    Price-to-Sales 7.89
    Price-to-Book 1.74
    PEG Ratio -0.05
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 10.63
    Resistance 3 (R3) 10.57 10.25 10.50
    Resistance 2 (R2) 10.25 10.05 10.28 10.46
    Resistance 1 (R1) 10.05 9.93 10.15 10.11 10.41
    Pivot Point 9.73 9.73 9.78 9.76 9.73
    Support 1 (S1) 9.53 9.53 9.63 9.59 9.29
    Support 2 (S2) 9.21 9.41 9.24 9.24
    Support 3 (S3) 9.01 9.21 9.20
    Support 4 (S4) 9.07